Entry |
|
Name |
ERBB2-overexpression to RAS-ERK signaling pathway
|
Definition |
EGF -> (ERBB2*+EGFR) -> GRB2 -> SOS -> RAS -> RAF -> MEK -> ERK |
Expanded |
1950 -> (2064v1+1956) -> 2885 -> (6654,6655) -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00014 | Non-small cell lung cancer |
|
Gene |
1950 | EGF; epidermal growth factor |
2064 | ERBB2; erb-b2 receptor tyrosine kinase 2 |
1956 | EGFR; epidermal growth factor receptor |
2885 | GRB2; growth factor receptor bound protein 2 |
6654 | SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 |
6655 | SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 |
3265 | HRAS; HRas proto-oncogene, GTPase |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
5594 | MAPK1; mitogen-activated protein kinase 1 |
5595 | MAPK3; mitogen-activated protein kinase 3 |
|
Variant |
2064v1 (ERBB2*) ERBB2 overexpression
|
Reference |
|
Authors |
Wolff EM, Liang G, Jones PA. |
Title |
Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer. |
Journal |
|
Reference |
|
Authors |
Mitra AP, Datar RH, Cote RJ. |
Title |
Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification. |
Journal |
|
Reference |
|
Authors |
Eroles P, Bosch A, Perez-Fidalgo JA, Lluch A |
Title |
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. |
Journal |
|
Reference |
|
Authors |
Dittrich A, Gautrey H, Browell D, Tyson-Capper A |
Title |
The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web. |
Journal |
|
LinkDB |
|